A Trial of the Safety and Efficacy of SEP-363856 in the Treatment of Adults With Major Depressive Disorder
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05593029 |
|
Recruitment Status :
Recruiting
First Posted : October 25, 2022
Last Update Posted : March 13, 2024
|
Sponsor:
Otsuka Pharmaceutical Development & Commercialization, Inc.
Collaborators:
Sumitomo Pharma Co., Ltd.
Sumitomo Pharma America, Inc.
Information provided by (Responsible Party):
Otsuka Pharmaceutical Development & Commercialization, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | May 2025 |
| Estimated Study Completion Date : | May 2025 |